results tracker 07.11.2013

3

Click here to load reader

Upload: mansukh-investment-amp-trading-solutions

Post on 14-Jun-2015

55 views

Category:

Economy & Finance


4 download

DESCRIPTION

Results Tracker Update 07 November 2013 Mansukh Investment and Trading Solution

TRANSCRIPT

Page 1: Results Tracker 07.11.2013

Mansukh Securities and Finance LtdOffice: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: [email protected]: www.moneysukh.com

SEBI Regn No. BSE: INB010985834 / NSE: INB230781431PMS Regn No. INP000002387

Please refer to important disclosures at the end of this report For Private circulation Only For Our Clients Only

make more, for sure.

Results Tracker Thursday,07 November 2013

Q2FY14

Aarya Global Shares DLINK IND ITI Prestige Estates Tourism Fin Corp

Allsec Tech Eicher Motors JJ Finance Prime Cap TPL Plastech

Arvind Remedies Glodyne Tech Kabra Extr Radico Khaitan TRF

Asian Tea Godavari Drugs KBS INDIA Rajdhani Leas Triveni Engr

ATV Projects Gokak Textiles Lakhotia Poly Redington India TV Today

Aurobindo Phar Goodricke Group Lakshmi Auto Loom Riverdale Foods TVS Electronics

Bengal Steel Hinduja Found Loyal Textile Rossell India Unisys Soft

Bhagiradha Che Hinduja Vent Mahavir Adv Sarthak Global United Brew

Capital Trust HSIL Mardia Samyoung Senbo Inds Universal Prime

Caplin Point ICDS Marigold Glass Setco Auto VA Tech Wabag

Century Extr India Cements MM Forgings Shalimar Wires VCCL

Chennai Petro Indian Extr Modella Wool Shreyans Inds Vimta Labs

CNI Research Indsil Hydro MOIL Spicejet Warner Multi

Control Print Ingersoll Rand Nagarjuna Oil Ref Stewarts & Lloyds Yash Management

Cosmo Ferrites Intec Cap Network Suryalakshmi

Cummins India Intl Data Mgmt PCS Technology Tata Coffee

Disa India ITD Cem India Plastiblends Tech Mahindra

Results to be Declared on 7th November 2013COMPANIES NAME

Quarter ended Year to Date Year ended

201309 201209 % Var 201309 201209 % Var 201303 201203 % Var

Sales 10100.3 8551.9 18.11 19127.3 16158.7 18.37 33669.99 25178.36 33.73

Other Income 38.4 33.07 16.12 76.5 64.47 18.66 128.96 75.12 71.67

PBIDT 1501.8 2098.91 -28.45 3479.1 3927.61 -11.42 7710.38 6411.74 20.25

Interest 98.1 140.33 -30.09 226.1 295.53 -23.49 561.93 478.84 17.35

PBDT 1403.7 1958.58 -28.33 3253 3632.08 -10.44 7148.45 5932.9 20.49

Depreciation 0 477.03 0 531.5 903.83 -41.19 1866.58 1431.98 30.35

PBT 1403.7 1481.55 -5.25 2721.5 2728.25 -0.25 5281.87 4500.92 17.35

TAX 476.2 489.42 -2.7 918.2 885.62 3.68 1740.62 1436.6 21.16

Deferred Tax 0 0 0 0 0 0 0 0 0

PAT 927.5 992.13 -6.51 1803.3 1842.63 -2.13 3541.25 3064.32 15.56

Equity 1400 1400 0 1400 1400 0 1400 1400 0

PBIDTM(%) 14.87 24.54 -39.42 18.19 24.31 -25.17 22.9 25.47 -10.07

Results Announced on 06th November 2013 (Rs Million)

� he revenue zoomed 18.11% to Rs. 10100.30 millions for the quarter ended September 2013 as compared to Rs. 8551.90 millions during

� he corresponding quarter last year.The Net Profit of the company registered a slight decline of -6.51% to Rs. 927.50 millions from Rs.

� 92.13 millions.Operating profit for the quarter ended September 2013 decreased to 1501.80 millions as compared to 2098.91 millions of

corresponding quarter ended September 2012.

Indraprastha Gas

Page 2: Results Tracker 07.11.2013

SEBI Regn No. BSE: INB010985834 / NSE: INB230781431PMS Regn No. INP000002387

Mansukh Securities and Finance LtdOffice: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: [email protected]: www.moneysukh.com

SEBI Regn No. BSE: INB010985834 / NSE: INB230781431PMS Regn No. INP000002387

Please refer to important disclosures at the end of this report For Private circulation Only For Our Clients Only

make more, for sure.

Results Tracker Q2FY14

Results Announced on 06th November 2013 (Rs Million)

Quarter ended Year to Date Year ended

201309 201209 % Var 201309 201209 % Var 201212 201112 % Var

Sales 10140.8 8577 18.23 28797.6 24525.4 17.42 31875 27650.1 15.28

Other Income 433.9 276.1 57.15 1143.6 806 41.89 1137.9 852.5 33.48

PBIDT 2238.4 1982.5 12.91 6571.5 5756.8 14.15 7172 5897.1 21.62

Interest 1.4 2.7 -48.15 4.4 22.8 -80.7 24.2 34.7 -30.26

PBDT 2237 1979.8 12.99 6567.1 5734 14.53 7147.8 5862.4 21.93

Depreciation 0 77 0 229 281.7 -18.71 360.8 459.8 -21.53

PBT 2237 1902.8 17.56 6338.1 5452.3 16.25 6787 5402.6 25.62

TAX 767.7 617.3 24.36 2105.1 1781.1 18.19 2119.3 1850.5 14.53

Deferred Tax 0 0 0 0 0 0 0 0 0

PAT 1469.3 1285.5 14.3 4233 3671.2 15.3 4667.7 3552.1 31.41

Equity 420.6 420.6 0 420.6 420.6 0 420.6 420.6 0

PBIDTM(%) 22.07 23.11 -4.5 22.82 23.47 -2.78 22.5 21.33 5.5

Glaxo.Cons. Health

The company witnessed a 18.23% growth in the revenue at Rs. 10140.80 millions for the quarter ended September 2013 as compared to

? s. 8577.00 millions during the year-ago period.A slim rise of 14.30% was recorded in the Net profit for the quarter ended September 2013

to Rs. 1469.30 millions From Rs. 1285.50 millions.OP of the company witnessed a marginal growth to 2238.40 millions from 1982.50

millions in the same quarter last year.

Quarter ended Year to Date Year ended

201309 201209 % Var 201309 201209 % Var 201303 201203 % Var

Sales 89843.5 105615.5 -14.93 154424.7 190005.6 -18.73 484246.5 479788.9 0.93

Other Income 4979 1306.7 281.04 10363.8 4969.4 108.55 11217.1 12655.5 -11.37

PBIDT 9098.3 20301.4 -55.18 18368.9 35986 -48.96 105111 111535.4 -5.76

Interest 246.6 258.6 -4.64 524.2 313.8 67.05 1252.7 512.8 144.29

PBDT 8851.7 20042.8 -55.84 17844.7 35672.2 -49.98 103858.3 111022.6 -6.45

Depreciation 2386.8 2163.1 10.34 4694.8 4447 5.57 9533.9 8000 19.17

PBT 6464.9 17879.7 -63.84 13149.9 31225.2 -57.89 94324.4 103022.6 -8.44

TAX 1905.4 5135.2 -62.9 3936.1 9271.7 -57.55 28177.1 32623 -13.63

Deferred Tax 0 0 0 0 0 0 0 0 0

PAT 4559.5 12744.5 -64.22 9213.8 21953.5 -58.03 66147.3 70399.6 -6.04

Equity 4895.2 4895.2 0 4895.2 4895.2 0 4895.2 4895.2 0

PBIDTM(%) 9.6 18.17 -47.19 11.9 18.94 -37.19 20.62 22.19 -7.06

BHEL

The sales declined to Rs. 89843.50 millions for the September 2013 quarter as compared to Rs. 105615.50 millions during the

corresponding quarter last year.Net profit of the cmpany stood at Rs. 4559.50 millions for the quarter ended September 2013 a decline of -

64.22% from Rs. 12744.50 millions in the same quarter last year.The Operating Profit of the company witnessed a decrease to 9098.30

millions from 20301.40 millions.

Page 3: Results Tracker 07.11.2013

SEBI Regn No. BSE: INB010985834 / NSE: INB230781431PMS Regn No. INP000002387

Mansukh Securities and Finance LtdOffice: 306, Pratap Bhavan, 5, Bahadur Shah Zafar Marg, New Delhi-110002Phone: 011-30123450/1/3/5 Fax: 011-30117710 Email: [email protected]: www.moneysukh.com

SEBI Regn No. BSE: INB010985834 / NSE: INB230781431PMS Regn No. INP000002387

Please refer to important disclosures at the end of this report For Private circulation Only For Our Clients Only

make more, for sure.

Data Source : ACE Equity

This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. Mansukh Securities and Finance Ltd (hereinafter referred as MSFL) is not soliciting any action based on it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any person in any form.The report is based upon information that we consider reliable, but we do not represent that it is accurate or complete. MSFL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MSFL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. MSFL and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. This information is subject to change without any prior notice. MSFL reserves the right to make modifications and alterations to this statement as may be required from time to time. Nevertheless, MSFL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries.

NAME DESIGNATION E-MAIL

Varun Gupta Head - Research [email protected]

Mohit Taneja Research Analyst [email protected]

Results Tracker Q2FY14